99mTc-maraciclatide Granted FDA Fast Track Designation for the Visualization of Inflammation in Interstitial Lung Disease

Serac Healthcare Limited, a clinical radiopharmaceutical company developing an innovative molecular imaging agent, announced ...
Scientific Research Publishing

Progress in Quantitative Imaging Assessment of Dermatomyositis-Associated Interstitial Lung Disease ()

Tu, H. and Huang, Y.Y. (2026) Progress in Quantitative Imaging Assessment of Dermatomyositis-Associated Interstitial Lung ...

Pulmovant Announces Completion of Enrollment in the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

PHocus enrollment completed in under 12 months from first patient dosed, representing a rapid enrollment pace in pulmonary hypertension ...

Tunable-pore microneedles dramatically speed up interstitial fluid sampling

Interstitial fluid mirrors many biomarkers found in blood and has attracted growing interest as a target for painless diagnostics. Microneedles offer a way to access this fluid through the skin, but ...
Pulmonary Hypertension News

Cereno broadens focus for its experimental lung therapy to PH-ILD

Cereno Scientific is expanding development of CS014 to treat pulmonary hypertension linked to interstitial lung disease.
Pulmonology Advisor

Prognostic Tool Assesses Exertional Desaturation Recovery Post-6MWT in fILD

In fibrotic ILD, desaturation recovery post 6MWT is linked to disease progression, baseline disease severity, and transplant-free survival.

Cereno Scientific broadens development focus for CS014 to pulmonary hypertension associated with interstitial lung disease

Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...